USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: BCR DIAGNOSTICS, INC.
City: PHOENIX
State: AZ
Zip+4: 85048-
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $581,334.00 5
SBIR Phase II $1,438,226.00 2

Award List:

Test for Occult Micrometastases in Primary Breast Cancer

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: M. Rotman
Award Amount: $62,336.00
Abstract:
We will develop and validate a new assay system to replace existing immunocytochemicalassays for detecting occult micrometastases in bone marrow of patients with primary breast cancer.This assay would offer simplicity, low cost, and a quantitative end point. The assay is based on aninnovative… More

REAL-TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Boris Rotman
Award Amount: $136,210.00
Abstract:
DESCRIPTION (Provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to demonstrate the feasibility of adapting its LEXSAS (Label-free Exponential Signal-Amplification System) technology for real-time bacteriologic analysis of blood products intended for transfusion. The LEXSAS technology is… More

REAL TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES

Award Year / Program / Phase: 2003 / SBIR / Phase II
Agency: HHS
Principal Investigator: Boris Rotman
Award Amount: $739,219.00
Abstract:
DESCRIPTION (provided by applicant): Bacterial contamination of blood products is currently a major problem in transfusion medicine and a leading cause of transfusion-related deaths. Platelets are particularly susceptible to contamination because they are stored at room temperature. BCR… More

LOW-COST BIOSENSOR FOR REAL-TIME DIAGNOSIS OF BACTEREMIA

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: M. B. Rotman
Award Amount: $137,221.00
Abstract:
DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to study the feasibility of applying its low-cost biosensor technology to detecting bacteremia in real-time (i.e., less than 5 min). The premise underlying the application is that early diagnosis of bacteremia is crucial… More

Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Boris Rotman
Award Amount: $99,930.00
Abstract:
DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacillus spores. Fluorogenic spores (F-spores) produced at BCR appear to be physiologically identical… More

Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Boris Rotman
Award Amount: $699,007.00
Abstract:
DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacillus spores. Fluorogenic spores (F-spores) produced at BCR appear to be phy siologically identical to normal spores… More

Ultrasensitive Detection of Hepatitis Viruses by Immunoassay Amplification

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Boris Rotman – 401-849-9957
Award Amount: $145,637.00
Abstract:
DESCRIPTION (provided by applicant): This proposal responds to the action plan for combating the Silent Epidemic of Viral Hepatitis recently launched by the National Institutes of Health by focusing on early diagnosis of hepatitis, which is crucial for preventing further infections and to improve… More